Skip to main content
. 2023 Jan 9;49(1):50–61. doi: 10.1007/s00134-022-06937-1

Table 1.

Characteristics of patients, overall and stratified according to the use of extreme therapies (eTIL) over the first week since ICU admission

Characteristics Overall
N = 2320
No eTIL
N = 2025 (87.3%)
eTIL
N = 295 (12.7%)
p value
Age (years), median (I-III quartiles) 55 (39, 69) 56 (40, 69) 49.00 (35, 62)  < 0.001
Female, n (%) 800 (34.5) 694 (34.3) 106 (35.9) 0.621
Low-Middle income countries, n (%) 409 (17.6) 356 (17.6) 53 (18) 0.936
Alcohol use, n (%) 269 (63) 232 (62.5) 37 (66.1) 0.717
Drug use, n (%) 83 (21.1) 71 (20.7) 12 (24) 0.727
Smoker, n (%) 274 (66.8) 239 (66.4) 35 (70) 0.728
Cardiovascular history, n (%) 949 (42.4) 859 (44) 90 (31.4)  < 0.001
Hypertension, n (%) 844 (89.2) 764 (89.1) 80 (89.9) 0.972
Neurological comorbidities, n (%) 279 (12.5) 243 (12.4) 36 (12.6) 1.000
Diagnosis, n (%) 0.014
 ICH 572 (24.7) 518 (25.6) 54 (18.3)
 SAH 409 (17.6) 346 (17.1) 63 (21.4)
 TBI 1339 (57.7) 1161 (57.3) 178 (60.3)
Pupils at admission, n (%) 0.346
 Both reactive 1443 (66) 1268 (66.4) 175 (63.2)
 One reactive 260 (11.9) 220 (11.5) 40 (14.4)
 Both unreactive 484 (22.1) 422 (22.1) 62 (22.4)
GCS ≤ 8 at admission, n (%) 1916 (85.6) 1673 (85.3) 243 (87.7) 0.319
GCS at admission, n (%) 0.516
 3–5 1164 (52) 1019 (51.9) 145 (52.3)
 6–8 752 (33.6) 654 (33.3) 98 (35.4)
 > 8 323 (14.4) 289 (14.7) 34 (12.3)
Neuroworsening*, n (%) 813 (36.2) 653 (33.3) 160 (56.1)  < 0.001
Neurosurgical intervention at day 1, n (%) 349 (15) 286 (14.1) 63 (21.4) 0.002
ICPm, n (%) 1258 (54.2) 1037 (51.2) 221 (74.9)  < 0.001
Highly pathological CT scan, n (%) 1494 (64.4) 1288 (63.6) 206 (69.8) 0.043

N number, GCS Glasgow Coma Scale, ICH Intracerebral haemorrhage, SAH Subarachnoid haemorrhage, TBI Traumatic brain injury, ICPm Intracranial pressure monitoring

*Neuroworsening was defined as one or more of the following: a spontaneous decrease in the GCS motor score of 2 points or more compared with the previous examination; a new loss of pupillary reactivity, development of pupillary asymmetry ≥ 2 mm deterioration in neurological or Computed Tomography status sufficient to warrant immediate medical or surgical intervention; CT scan, defined as Marshall classification 3 or more (for patients with TBI), Fisher grade 3 or more (for patients with subarachnoid haemorrhage), or intracranial haemorrhage volume 30 mL or more (for patients with intracranial haemorrhage)